327 related articles for article (PubMed ID: 27384875)
1. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.
Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C
Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875
[TBL] [Abstract][Full Text] [Related]
2. YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma.
Guo T; Zhao S; Wang P; Xue X; Zhang Y; Yang M; Li N; Li Z; Xu L; Jiang L; Zhao L; Ma PC; Rosell R; Li J; Gu C
Oncotarget; 2017 Jul; 8(29):48110-48125. PubMed ID: 28624808
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
Qin H; Liu W
J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
[TBL] [Abstract][Full Text] [Related]
4. Regulatory mechanism of interaction between Y-box-binding protein 1 and heterogenous nuclear ribonucleoprotein K in cell division cycle 25a signal pathway and lung cancer metastasis.
Fu L; Yang M; Ma Y
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):62-68. PubMed ID: 38279484
[TBL] [Abstract][Full Text] [Related]
5. Yifei Sanjie formula alleviates lung cancer progression via regulating PRMT6-YBX1-CDC25A axis.
Tang J; Yin C; Chen M; Dong M; Xu Y
Environ Toxicol; 2024 May; 39(5):3225-3237. PubMed ID: 38357781
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
7. LncRNA LINC00472 regulates cell stiffness and inhibits the migration and invasion of lung adenocarcinoma by binding to YBX1.
Deng X; Xiong W; Jiang X; Zhang S; Li Z; Zhou Y; Xiang B; Zhou M; Li X; Li G; Zeng Z; Gong Z
Cell Death Dis; 2020 Nov; 11(11):945. PubMed ID: 33144579
[TBL] [Abstract][Full Text] [Related]
8. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
[TBL] [Abstract][Full Text] [Related]
11. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
12. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression.
Chen QN; Chen X; Chen ZY; Nie FQ; Wei CC; Ma HW; Wan L; Yan S; Ren SN; Wang ZX
Mol Cancer; 2017 Jan; 16(1):17. PubMed ID: 28109288
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.
Johnson TG; Schelch K; Cheng YY; Williams M; Sarun KH; Kirschner MB; Kao S; Linton A; Klebe S; McCaughan BC; Lin RCY; Pirker C; Berger W; Lasham A; van Zandwijk N; Reid G
J Thorac Oncol; 2018 Feb; 13(2):258-272. PubMed ID: 29113949
[TBL] [Abstract][Full Text] [Related]
14. Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma.
Liang C; Ma Y; Yong L; Yang C; Wang P; Liu X; Zhu B; Zhou H; Liu X; Liu Z
Cancer Sci; 2019 Jan; 110(1):166-179. PubMed ID: 30426615
[TBL] [Abstract][Full Text] [Related]
15. CDC25A mRNA levels significantly correlate with Ki-67 expression in human glioma samples.
Yamashita Y; Kasugai I; Sato M; Tanuma N; Sato I; Nomura M; Yamashita K; Sonoda Y; Kumabe T; Tominaga T; Katakura R; Shima H
J Neurooncol; 2010 Oct; 100(1):43-9. PubMed ID: 20217459
[TBL] [Abstract][Full Text] [Related]
16. YBX1 mediates autophagy by targeting p110β and decreasing the sensitivity to cisplatin in NSCLC.
Cui Y; Li F; Xie Q; Zhao S; Guo T; Guo P; Hu S; Hao J; Tian C; Yu W; Li Z; Fang L; Zhao L; Chen M; Wu T; Gu C
Cell Death Dis; 2020 Jun; 11(6):476. PubMed ID: 32561752
[TBL] [Abstract][Full Text] [Related]
17. Silencing of Long Noncoding RNA
Su W; Feng S; Chen X; Yang X; Mao R; Guo C; Wang Z; Thomas DG; Lin J; Reddy RM; Orringer MB; Chang AC; Yang Z; Beer DG; Chen G
Cancer Res; 2018 Jun; 78(12):3207-3219. PubMed ID: 29669758
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
19. RAN and YBX1 are required for cell proliferation and IL-4 expression and linked to poor prognosis in oral squamous cell carcinoma.
Che X; Liu M; Li D; Li Z; Guo J; Jia R
Exp Cell Res; 2021 Sep; 406(2):112767. PubMed ID: 34364882
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers.
Guo W; Lu J; Dai M; Wu T; Yu Z; Wang J; Chen W; Shi D; Yu W; Xiao Y; Yi C; Tang Z; Xu T; Xiao X; Yuan Y; Liu Q; Du G; Deng W
Oncotarget; 2014 Oct; 5(19):9349-61. PubMed ID: 25294805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
